Amagai M - Search Results

1

Generation of human melanocytes from induced pluripotent stem cells.

Ohta S, Imaizumi Y, Okada Y, Akamatsu W, Kuwahara R, Ohyama M, Amagai M, Matsuzaki Y, Yamanaka S, Okano H, Kawakami Y. Ohta S, et al. Among authors: amagai m. PLoS One. 2011 Jan 13;6(1):e16182. doi: 10.1371/journal.pone.0016182. PLoS One. 2011. PMID: 21249204 Free PMC article.

2

Clinical phenotype and anti-desmoglein autoantibody profile in paraneoplastic pemphigus.

Ohyama M, Amagai M, Hashimoto T, Nousari HC, Anhalt GJ, Nishikawa T. Ohyama M, et al. Among authors: amagai m. J Am Acad Dermatol. 2001 Apr;44(4):593-8. doi: 10.1067/mjd.2001.112222. J Am Acad Dermatol. 2001. PMID: 11260531

3

[Bullous pemphigoid].

Ohyama M, Amagai M. Ohyama M, et al. Among authors: amagai m. Ryoikibetsu Shokogun Shirizu. 2000;(31):274-6. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269078 Review. Japanese. No abstract available.

4

[Herpes gestationis].

Ohyama M, Amagai M. Ohyama M, et al. Among authors: amagai m. Ryoikibetsu Shokogun Shirizu. 2000;(31):277-8. Ryoikibetsu Shokogun Shirizu. 2000. PMID: 11269079 Review. Japanese. No abstract available.

5

A Case of pemphigus foliaceus which occurred after five years of remission from pemphigus vulgaris.

Kimoto M, Ohyama M, Hata Y, Amagai M, Nishikawa T. Kimoto M, et al. Among authors: amagai m. Dermatology. 2001;203(2):174-6. doi: 10.1159/000051737. Dermatology. 2001. PMID: 11586021

6

Immunologic and histopathologic characterization of an active disease mouse model for pemphigus vulgaris.

Ohyama M, Amagai M, Tsunoda K, Ota T, Koyasu S, Hata J, Umezawa A, Nishikawa T. Ohyama M, et al. Among authors: amagai m. J Invest Dermatol. 2002 Jan;118(1):199-204. doi: 10.1046/j.0022-202x.2001.01643.x. J Invest Dermatol. 2002. PMID: 11851895 Free article.

7

Pathogenic autoantibody production requires loss of tolerance against desmoglein 3 in both T and B cells in experimental pemphigus vulgaris.

Tsunoda K, Ota T, Suzuki H, Ohyama M, Nagai T, Nishikawa T, Amagai M, Koyasu S. Tsunoda K, et al. Among authors: amagai m. Eur J Immunol. 2002 Mar;32(3):627-33. doi: 10.1002/1521-4141(200203)32:3<627::AID-IMMU627>3.0.CO;2-1. Eur J Immunol. 2002. PMID: 11857336 Free article.

8

Suppression of the immune response against exogenous desmoglein 3 in desmoglein 3 knockout mice: an implication for gene therapy.

Ohyama M, Ota T, Aoki M, Tsunoda K, Harada R, Koyasu S, Nishikawa T, Amagai M. Ohyama M, et al. Among authors: amagai m. J Invest Dermatol. 2003 Apr;120(4):610-5. doi: 10.1046/j.1523-1747.2003.12090.x. J Invest Dermatol. 2003. PMID: 12648224 Free article.

9

Aleukaemic leukaemia cutis as an initial manifestation of myeloid/NK cell precursor acute leukaemia.

Dekio I, Anzai H, Ohyama M, Tanikawa A, Amagai M, Yokoyama K, Okamoto S, Tanaka M. Dekio I, et al. Among authors: amagai m. J Eur Acad Dermatol Venereol. 2006 Apr;20(4):453-6. doi: 10.1111/j.1468-3083.2006.01491.x. J Eur Acad Dermatol Venereol. 2006. PMID: 16643148

10

T helper type 2-biased natural killer cell phenotype in patients with pemphigus vulgaris.

Takahashi H, Amagai M, Tanikawa A, Suzuki S, Ikeda Y, Nishikawa T, Kawakami Y, Kuwana M. Takahashi H, et al. Among authors: amagai m. J Invest Dermatol. 2007 Feb;127(2):324-30. doi: 10.1038/sj.jid.5700527. Epub 2006 Aug 31. J Invest Dermatol. 2007. PMID: 16946717 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

545 results

Search Page